VAERS Explorer
Back to explore

Report #2878494

Received Dec 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
VA
Recovered
Unknown
Vaccinated
Dec 3, 2025
Onset
Dec 3, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKZ010729OT

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

No additional AEs or PQC reported.; PROQUAD was administered to a 16 year old patient.; This spontaneous report was received from a Nurse and refers to a 16-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 03-Dec-2025, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) lot #Z010729, expiration date: 22-Dec-2026, 0.5 mL, administered by Intramuscular route (strength, dose number, and anatomical location were not provided) (Inappropriate age at vaccine administration) No adverse event reported.

Other medications

Sterile diluent